Published in
Dove Medical Press, Cancer Management and Research, (Volume 11), p. 4449-4459, 2019
DOI: 10.2147/cmar.s189626
Links
Tools
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial
Journal article published in 2019 by
Xing-Sheng Hu,
Xiao-Hong Han,
Sheng Yang,
Ning Li,
Lin Wang,
Yuan-Yuan Song,
Hua Mu,
Yuan-Kai Shi
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 
